Alembic gets FDA nod for generic ZanaflexTizanidine hydrochloride had a market value of roughly $28 million for the 12 months ended September 2019, according to IQVIA. NCPA to CMS: Recognize pharmacist services beyond dispensingThe National Community Pharmacists Association is urging CMS to allow pharmacists to practice at the top of their licenses. Mockingbird Pharma receives NCDQS accreditation Mockingbird Pharma is the second facility to meet NCDQS' strict accreditation approval criteria. FDA clears Horizon Therapeutics’ Tepezza Tepezza is the first approved treatment for thyroid eye disease. Rapid uptake in generics, biosimilars are key in improving medicine access Although polices have been introduced to increase the use of generics and biosimilars, large differences remain in the price and uptake of these medicines between countries. CVS Health brings HealthHub format to Florida market Nine HealthHub locations in Tampa, Fla., will offer chronic disease management and overall health-and-wellness products and services. Hikma, Arecor to develop ready-to-use injectable medicine Hikma and Arecor's new product uses Arecor’s drug formulation technology platform Arestat. Vaccination partnership expands immunization access in New Jersey More than 1,500 vaccinations have been administered in the first five months of a new vaccination program. IPA member pharmacies to get access to Green Roads' CBD products The Independent Pharmacy Alliance will offer member pharmacies Green Roads' full line of CBD products. FDA clears new indication for Novo Nordisk’s Ozempic Novo Nordisk's Ozempic now is approved to reduce cardiovascular risk in Type 2 diabetes patients with heart disease. First Previous 415 416 417 418 419 Next Last